{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00576",
      "entity_text" : "DPP4 inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Beside the glucose lowering properties of DPP4 inhibitors, emerging evidence suggests that incretin based therapies may also have a positive impact on inflammation, cardiovascular and hepatic health, sleep, and the central nervous system.",
  "reading_complete" : "2020-08-04T09:52:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:47:07Z",
  "trigger" : "lowering",
  "evidence" : [ "glucose-lowering properties of DPP4 inhibitors" ],
  "pmc_id" : "4515598",
  "score" : 0
}